MTOR and endometrial cancer: Previous research, such as that by Cantrell et al. and Xie et al., demonstrated that metformin inhibits cancer cell proliferation and promotes progesterone receptor expression in endometrial cancer, effects partially mediated through inhibition of the mTOR pathway [39,40].